No Data
No Data
No Data
No Data
No Data
Shisi Pharmaceutical Group (02005) has obtained drug production registration approval for linezolid dry suspension (5ml: 100mg)
Shisi Pharmaceutical Group (02005) issued an announcement. The group has obtained the relevant linezolamide dry mix from the China National Drug Administration...
Zhitong FinanceApr 23 00:06 ET
Is SSY Group (HKG:2005) Using Too Much Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know wor
Simply Wall StApr 18 22:49 ET
Zhitong Hong Kong Shareholders' Rights Disclosure | April 19
Disclosure of Hong Kong Stock Shareholders' Rights | April 19
Zhitong FinanceApr 18 20:05 ET
Shi Siyao Group (02005.HK) was increased by 1 million shares by executive director Qu Jiguang
Gelonghui, April 19丨According to the latest equity disclosure data of the Stock Exchange, on April 18, 2024, Shijiyao Group (02005.HK) obtained an increase of 1 million shares by Executive Director Qu Jiguang at an average price of HK$4.6752 per share on the market, involving approximately HK$4.6752 million. After increasing his holdings, Qu Jiguang's latest shareholding was 1,117,706,000 shares, and the shareholding ratio increased from 37.61% to 37.65%.
Gelonghui FinanceApr 18 18:48 ET
石四藥集團:2023 年報
Futu NewsApr 18 04:39 ET · Announcements
Zhitong Hong Kong Shareholders' Rights Disclosure | April 18
Disclosure of Hong Kong Stock Shareholders' Rights | April 18
Zhitong FinanceApr 17 20:05 ET
No Data
No Data